EUVIMEDEUVIMED entdecken
Crossref

Impact of transforming growth factor-β2 enriched food for special medical purposes on nutritional status, microbiota and clinical outcomes after allogeneic hematopoietic stem cell transplantation: prospective analysis of 192 consecutive patients

E Morello, S Roversi, G Brambilla, S Bernardi, A Leoni, A Zanchi, G Bignotti, M Farina, V Radici, D Avenoso, V Villanacci, G Magliano und 8 weitere

Clinical Nutrition ESPEN · 2025

DOI: 10.1016/j.clnesp.2025.06.044 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Nutrition ESPEN, 2025. Verfasst von E Morello und 19 weiteren Autor:innen. Beteiligte Einrichtung: Unit of Blood Diseases and Bone Marrow Transplantation, Department of Clinical and Experimental Sciences, University of Brescia, ASST Spedali Civili …. Hauptthemen laut MEDLINE: Hematopoietic Stem Cell Transplantation, Nutritional Status, Gastrointestinal Microbiome, Transforming Growth Factor beta2. Die Arbeit nennt 44 Literaturangaben. Gefördert von: Italian Association Against Leukemia-Lymphoma and Myeloma ONLUS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND AND AIMS: Allogeneic hematopoietic stem cell transplantation (allo-HSCT) represents an essential treatment for various diseases despite being burdened by severe malnutrition, serious infections, graft-versus-host disease (GVHD) and gut microbiota dysbiosis. There is growing evidence suggesting that nutritional interventions may potentially lower these risks. In particular, nutritional supports enriched with the TGF-β2 have shown promising benefits in Crohn's disease thanks to its immunomodulating and anti-inflammatory properties. Given the pathophysiological and clinical similarities between IBDs (Inflammatory Bowel Diseases) and gastrointestinal acute GVHD (GI aGVHD), this prospective study investigated the impact of a TGF-β2 enriched Food for Special Medical Purposes (TGF-β2 FSMP) on nutritional status, transplant outcomes, and microbiota composition in patients undergoing allo-HSCT. METHODS: Patients were divided into two groups according to their TGF-β2 FSMP consumption defined by study protocol: Group A (Treatment Ratio ≥50 %, more than 50 % of prescribed FSMP assumed) and Group B (Treatment Ratio

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hematopoietic Stem Cell TransplantationNutritional StatusGastrointestinal MicrobiomeTransforming Growth Factor beta2HumansProspective StudiesFemaleMaleAdultMiddle AgedGraft vs Host DiseaseYoung AdultTransplantation, HomologousTreatment OutcomeAdolescentAgedMalnutrition

Stichwörter der Autor:innen

Allogeneic Hematopoietic Stem Cell TransplantationGVHDMalnutritionTGF-beta2

Substanzen

Transforming Growth Factor beta2

Autor:innen und Institutionen

  • Unit of Blood Diseases and Bone Marrow Transplantation, Department of Clinical and Experimental Sciences, University of Brescia, ASST Spedali Civili di Brescia, 25123, Brescia, Italy. Electronic address: enrico.morello@…
  • Institute of Microbiology, Department of Molecular and Translational Medicine, University of Brescia, ASST Spedali Civili, 25123, Brescia, Italy.
  • Unit of Blood Diseases and Bone Marrow Transplantation, Department of Clinical and Experimental Sciences, University of Brescia, ASST Spedali Civili di Brescia, 25123, Brescia, Italy.
  • Department of Pathology, ASST Spedali Civili, 25123, Brescia, Italy.
  • Unit of Dietetics and Clinical Nutrition, ASST Spedali Civili, 25123, Brescia, Italy.
  • Unit of Gastroenterology and Hepatology, ASST-Spedali Civili, University of Brescia, 25123, Brescia, Italy.

Förderung

  • Italian Association Against Leukemia-Lymphoma and Myeloma ONLUS

Zitieren

APA

Morello, E., Roversi, S., Brambilla, G., Bernardi, S., Leoni, A., Zanchi, A., Bignotti, G., Farina, M., Radici, V., Avenoso, D., Villanacci, V., Magliano, G., Buttini, E. A., Andreoli, M., Ricci, C., Signorini, L., Fiorentini, S., Caruso, A., Russo, D., & Malagola, M. (2025). Impact of transforming growth factor-β2 enriched food for special medical purposes on nutritional status, microbiota and clinical outcomes after allogeneic hematopoietic stem cell transplantation: prospective analysis of 192 consecutive patients. Clinical Nutrition ESPEN. https://doi.org/10.1016/j.clnesp.2025.06.044

Vancouver

Morello E, Roversi S, Brambilla G, Bernardi S, Leoni A, Zanchi A, et al. Impact of transforming growth factor-β2 enriched food for special medical purposes on nutritional status, microbiota and clinical outcomes after allogeneic hematopoietic stem cell transplantation: prospective analysis of 192 consecutive patients. Clinical Nutrition ESPEN. 2025. doi:10.1016/j.clnesp.2025.06.044

BibTeX
@article{Morello2025,
  author = {Morello, E and Roversi, S and Brambilla, G and Bernardi, S and Leoni, A and Zanchi, A and Bignotti, G and Farina, M and Radici, V and Avenoso, D and Villanacci, V and Magliano, G and Buttini, E Accorsi and Andreoli, M and Ricci, C and Signorini, L and Fiorentini, S and Caruso, A and Russo, D and Malagola, M},
  title = {Impact of transforming growth factor-β2 enriched food for special medical purposes on nutritional status, microbiota and clinical outcomes after allogeneic hematopoietic stem cell transplantation: prospective analysis of 192 consecutive patients},
  journal = {Clinical Nutrition ESPEN},
  year = {2025},
  doi = {10.1016/j.clnesp.2025.06.044}
}
Kostenlos starten →